The last estimated annual incidence of Trichomonas vaginalis worldwide exceeds that of
chlamydia and gonorrhea combined. This critical review updates the state of the art on …

Trichomonas vaginalis is the most common curable sexually transmitted infection worldwide.
T vaginalis infections in women can range from asymptomatic to acute inflammatory …

Trichomonas vaginalis is the most common, curable non-viral sexually transmitted infection
(STI) worldwide. Despite this burden of disease, it is not currently a reportable disease in the …

The main objective is to assist practitioners in managing men and women diagnosed with
Trichomonas vaginalis (TV) infection. This guideline offers recommendations on the …

Future research to develop cheap, point-of-care diagnostic tests will allow a greater
understanding of T. vaginalis epidemiology. In addition, the effect of treatment on outcome of …

Trichomonas vaginalis is likely the most prevalent nonviral sexually transmitted infection,
affecting an estimated 3.7 million women and men in the United States. Health disparities …

Trichomonas vaginalis, a parasitic protozoan, is the etiologic agent of trichomoniasis, a
sexually transmitted disease (STD) of worldwide importance. Trichomoniasis is the most …

Trichomonas vaginalis is the most prevalent nonviral sexually transmitted infection, affecting
an estimated 3.7 million women and men in the United States. Health disparities are …

Trichomonas vaginalis is the most common nonviral sexually transmitted infection (STI) in
the world. It was once thought to be a nuisance STI, but it is now being recognized as an …

Trichomonas vaginalis was originally considered a commensal organism until the 1950s
when the understanding of its role as a sexually transmitted infection (STI) began to evolve …